Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48.9M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
5.22M
-
Shares change
-
+5.22M
-
Total reported value, excl. options
-
$47.7M
-
Value change
-
+$47.7M
-
Number of buys
-
11
-
Price
-
$9.25
Significant Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q4 2015
11 filings reported holding AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2015.
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.22M shares
of 48.9M outstanding shares and own 10.66% of the company stock.
Largest 10 shareholders include FMR LLC (2.87M shares), JPMORGAN CHASE & CO (1.56M shares), Lombard Odier Asset Management (USA) Corp (341K shares), SPHERA FUNDS MANAGEMENT LTD. (220K shares), Allianz Asset Management AG (117K shares), MILLENNIUM MANAGEMENT LLC (55.8K shares), GOLDMAN SACHS GROUP INC (24.4K shares), BlackRock Fund Advisors (13.7K shares), Bank of New York Mellon Corp (11.5K shares), and MORGAN STANLEY (6.87K shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.